Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition

NCT04454489 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Advanced Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma
Metastatic Head-and-neck Squamous-cell Carcinoma
Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck
Locally Advanced Head and Neck Squamous Cell Carcinoma
Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG: Pembrolizumab (immunotherapy)
RADIATION: Quad-shot palliative radiotherapy

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]